CTOs on the Move

HilleVax

www.hillevax.com

 
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hillevax.com
  • 75 State Street Suite 100
    Boston, MA USA 02109
  • Phone: 617.213.5054

Executives

Name Title Contact Details
Anju Chatterji
 Chief Technical Officer Profile

Similar Companies

Noramco

Noramco, Inc. is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sekisui Diagnostics

Sekisui Diagnostics, a global provider of innovative medical diagnostics to physicians and laboratories, has been committed to improving the lives of patients for over 30 years.

Global Blood Therapeutics

GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate, voxelotor (previously called GBT440), for the treatment of sickle cell disease.

deCODE genetics

deCODE genetics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Segetis

Segetis is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.